Eradicating Leprosy Using Genetics

Why It Matters

Molecular diagnostics can identify hidden leprosy cases and enable early treatment, dramatically increasing the likelihood of global eradication by 2030.

Key Takeaways

• Ancient Winchester burials reveal unmistakable leprosy lesions in skeletons
• World Health Organization targets global leprosy eradication by 2030
• Advanced DNA testing now enables rapid, accurate leprosy diagnosis
• Genetic screening of contacts reveals roughly 25% asymptomatic leprosy cases
• Early antibiotic treatment of identified cases could effectively halt transmission

Summary

The video links a 2007‑08 excavation at Magdalin Hill near Winchester, where paleopathologists identified unmistakable leprosy lesions in skeletal remains, to today’s fight against the disease.

Leprosy still generates roughly 200,000 new infections annually, and the World Health Organization has set a 2030 eradication target. Recent advances allow PCR‑based DNA testing of skin or nasal samples, turning a historically clinical diagnosis into a rapid molecular one.

Genetic screening of a patient’s close contacts routinely uncovers about a quarter of them as asymptomatic carriers, enabling early antibiotic therapy. The speaker highlights the fibula with new bone growth as a classic archaeological marker, now mirrored by modern molecular markers.

If widespread DNA testing and prophylactic treatment are adopted, transmission could be interrupted, making WHO’s 2030 goal realistic and reshaping leprosy control programs worldwide.

Original Description

Alice Roberts talks at New Scientist Live about how genetics could transform the way we combat leprosy, bringing us closer to eradication.

New Scientist Live 2026 is back. Join us for talks from Alice Roberts, Helen Sharman, Tim Spector, Giles Yeo and so many more.

Find out more: https://live.newscientist.com/